Medicon Hellas S.A. (ATH:MEDIC)

Greece flag Greece · Delayed Price · Currency is EUR
2.500
0.00 (0.00%)
Last updated: Mar 2, 2026, 12:26 PM EET
11.61%
Market Cap 10.96M
Revenue (ttm) 18.54M
Net Income (ttm) 1.90M
Shares Out 4.42M
EPS (ttm) 0.43
PE Ratio 5.90
Forward PE n/a
Dividend 0.13 (5.20%)
Ex-Dividend Date Jul 4, 2025
Volume n/a
Average Volume 2,561
Open 2.430
Previous Close 2.500
Day's Range 2.410 - 2.500
52-Week Range 1.929 - 2.920
Beta 0.57
RSI 38.95
Earnings Date Apr 24, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, contro... [Read more]

Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Founded 1988
Employees 151
Stock Exchange Athens Stock Exchange
Ticker Symbol MEDIC
Full Company Profile

Financial Performance

In 2024, Medicon Hellas's revenue was 18.12 million, an increase of 0.03% compared to the previous year's 18.12 million. Earnings were 1.37 million, an increase of 3.38%.

Financial Statements

News

There is no news available yet.